title: T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients.
abstract: The Mycobacterium tuberculosis-specific ESAT-6 antigen induces highly potent T-cell responses and production of gamma interferon (IFN-gamma), which play a critical role in protective cell-mediated immunity against tuberculosis (TB). In the present study, IFN-gamma secretion by peripheral blood mononuclear cells (PBMCs) in response to M. tuberculosis ESAT-6 in Brazilian TB patients was investigated in relation to clinical disease types, such as pleurisy and cavitary pulmonary TB. Leprosy patients, patients with pulmonary diseases other than TB, and healthy donors were assayed as control groups. Sixty percent of the TB patients indeed recognized M. tuberculosis ESAT-6, as did 50% of the leprosy patients and 60% of the non-TB controls. Nevertheless, the levels of IFN-gamma in response to the antigen ESAT, but not to antigen 85B (Ag85B) and purified protein derivative (PPD), were significantly lower in controls than in patients with treated TB or pleural or cavitary TB. Moreover, according to Mycobacterium bovis BCG vaccination status, only 59% of the vaccinated TB patients responded to ESAT in vitro, whereas 100% of them responded to PPD. Both CD4 and CD8 T cells were able to release IFN-gamma in response to ESAT. The present data demonstrate the specificity of ESAT-6 of M. tuberculosis and its ability to discriminate TB patients from controls, including leprosy patients. However, to obtain specificity, it is necessary to include quantitative IFN-gamma production in response to the antigen as well, and this might limit the use of ESAT-6-based immunodiagnosis of M. tuberculosis infection in an area of TB endemicity.
authors.affiliation: Leprosy Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
authors.forename: Fernando L L
authors.initials: FL
authors.lastname: Cardoso
authors.forename: Paulo R Z
authors.initials: PR
authors.lastname: Antas
authors.forename: Alexandre S
authors.initials: AS
authors.lastname: Milagres
authors.forename: Annemieke
authors.initials: A
authors.lastname: Geluk
authors.forename: Kees L M C
authors.initials: KL
authors.lastname: Franken
authors.forename: Eliane B
authors.initials: EB
authors.lastname: Oliveira
authors.forename: Henrique C
authors.initials: HC
authors.lastname: Teixeira
authors.forename: Susie A
authors.initials: SA
authors.lastname: Nogueira
authors.forename: Euzenir N
authors.initials: EN
authors.lastname: Sarno
authors.forename: Paul
authors.initials: P
authors.lastname: Klatser
authors.forename: Tom H M
authors.initials: TH
authors.lastname: Ottenhoff
authors.forename: Elizabeth P
authors.initials: EP
authors.lastname: Sampaio
mesh_terms: D000942:Antigens, Bacterial / Q000235:genetics / Q000276:immunology*; D001426:Bacterial Proteins; D001938:Brazil; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D008297:Male; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology; D014373:Tuberculin / Q000276:immunology; D014396:Tuberculosis, Pleural / Q000175:diagnosis / Q000276:immunology* / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000276:immunology* / Q000382:microbiology
chemical_list: D000942:Antigens, Bacterial; D001426:Bacterial Proteins; C093276:ESAT-6 protein, Mycobacterium tuberculosis; D011994:Recombinant Proteins; D014373:Tuberculin; D007371:Interferon-gamma